Short-pulse cardioversion system for an implantable cardioverter defibrillator

Claim 2

An improved implantable apparatus for producing a cardioversion waveform of less than about 5 Joules to be delivered to a plurality of implanted electrodes in a human patient the implantable apparatus including capacitor means for storing a preselected amount of electrical energy for the cardioversion waveform, high voltage charging circuit means for charging the capacitor means to the preselected amount of electrical energy, and switch means for selectively controlling a time-truncated discharge of the capacitor means through the plurality of electrodes in response to a means for sensing of the cardiac arrhythmia, the improvement comprising: the cardioversion waveform comprising at least one electrical pulse having a predetermined optimum pulse duration of between 0.5 ms and 6.0 ms.

Claim 3

The improved apparatus of claim 1 wherein the optimum pulse duration is the sum of: a first value derived from a first predetermined percentage of an RC time constant, with R being an inter-electrode resistance value between the plurality of electrodes and C being an effective capacitance value of the capacitor means; and a second value derived from a second predetermined percentage of a cardioversion chronaxie value.

Claim 4

The improved apparatus of claim 2 wherein the first and second predetermined values are between 0.4 and 0.8.

Claim 5

The improved apparatus of claim 1 wherein the optimum pulse duration is selected to be between 4.0 and 5.0 ms so as to reduce a stored energy requirement for delivering the cardioversion waveform and thereby decrease an overall displacement volume of the implantable apparatus.

Claim 6

The improved apparatus of claim 4 wherein the optimum pulse duration is selected to be between 4.5 and 04.8 ms.

Claim 7

The improved apparatus of claim 1 wherein the optimum pulse duration is selected to be a percentage tilt decay between an initial voltage value and a final voltage value where the percentage tilt is between about 34% and 64%.

Claim 8

The improved apparatus of claim 6 wherein the percentage tilt is between about 48% and 50%.

Claim 9

The apparatus of claim 1 wherein the optimum pulse duration is determined for a first pulse of a multiple pulse cardioversion waveform.

Claim 10

The apparatus of claim 1 wherein the optimum pulse duration is determined for a first phase of a multiphasic pulse cardioversion waveform.

Claim 11

The improved apparatus of claim 1 wherein the optimum pulse duration is a time period that is shorter than a first time constant that is a system time constant, RC, of the apparatus, where R is an inter-electrode resistance of the heart of the human patient and C is an effective capacitance of the capacitor means, and longer than a second time constant that is an average cardioversion chronaxie value of the heart of the human patient.

Claim 12

The apparatus of claim 1 wherein the predetermined optimum pulse duration is optimized for an amount of the preselected amount of electrical energy in the capacitor means that is delivered to the electrodes such that the predetermined pulse duration of the cardioversion waveform essentially matches an average cardioversion chronaxie value of the heart of the human patient, whereby an overall pain level of the cardioversion waveform is reduced.

Claim 13

The improved apparatus of claim 1 wherein the optimum pulse duration is selected to be between 0.5 ms and 3.0 ms so as to decrease pain induced in the human patient by the cardioversion waveform.

Claim 14

The improved apparatus of claim 12 wherein the optimum pulse duration is selected to be between 0.8 and 1.2 ms.

Claim 15

The improved apparatus of claim 1 wherein the optimum pulse duration is selected to be a percentage tilt decay between an initial voltage value and a final voltage value where the percentage tilt is between about 5% and 20%.

Claim 16

The improved apparatus of claim 14 wherein the percentage tilt is between about 12% and 16%.

Claim 17

An improved method for selecting an optimal pulse duration for operating an implantable cardioverter defibrillator device connected to a plurality of implanted electrodes located in a human patient to treat a cardiac arrhythmia, the implantable cardioverter defibrillator device being a self-contained human implantable device including a pulse-generating capacitor for storing an electrical charge, a battery for internally charging the pulse-generating capacitor, and a controller for selectively discharging the electrical charge in the pulse-generating capacitor through the plurality of electrodes in response to a sensing of a cardiac arrhythmia in the human patient, the improved method comprising the steps of: (a) selecting a predetermined optimum pulse duration for a time-truncated cardioversion waveform that is between 0.5 ms and 6.0 ms; and (b) setting the cardioverter defibrillator device to deliver the time-truncated cardioversion waveform such that the cardioversion waveform comprises at least one electrical pulse of less than about 5 Joules.

Claim 18

An improved method for selecting an optimal pulse duration for operating an implantable cardioverter defibrillator device connected to a plurality of implanted electrodes located in a human patient to treat a cardiac arrhythmia, the implantable cardioverter defibrillator device being a self-contained human implantable device including a pulse-generating capacitor for storing an electrical charge, a battery for internally charging the pulse-generating capacitor, and a controller for selectively discharging the electrical charge in the pulse-generating capacitor through the plurality of electrodes in response to a sensing of a cardiac arrhythmia in the human patient, the improved method comprising the steps of: (a) selecting a predetermined optimum pulse duration for a time-truncated cardioversion waveform that is between 0.5 ms and 6.0 ms; and (b) setting the cardioverter defibrillator device to deliver the time-truncated cardioversion waveform such that the cardioversion waveform comprises at least one electrical pulse of less than about 5 Joules.

Claim 19

The improved method of claim 16 wherein the optimum pulse duration is the sum of: a first value derived from a first predetermined percentage of an RC time constant, with R being an inter-electrode resistance value of the plurality of electrodes and C being an effective capacitance value of the capacitor; and a second value derived from a second predetermined percentage of a cardioversion chronaxie value.

Claim 20

The improved method of claim 17 wherein the first and second predetermined values are between 0.4 and 0.8.

Claim 21

The improved method of claim 16 wherein the optimum pulse duration is selected to be between 4.0 and 5.0 ms so as to reduce a stored energy requirement for delivering the cardioversion waveform and thereby decrease an overall displacement volume of the implantable device.

Claim 22

The improved method of claim 19 wherein the optimum pulse duration is between about 4.5 and 4.8 ms.

Claim 23

The improved method of claim 16 wherein the optimum pulse duration is measured by a percentage tilt decay between an initial voltage value and a final voltage value where the percentage tilt is between about 34% and 64%.

Claim 24

The improved method of claim 21 wherein the percentage tilt is between about 48% and 50%.

Claim 25

The method of claim 16 wherein the optimum pulse duration is determined for a first pulse of a multiple pulse cardioversion waveform.

Claim 26

The method of claim 16 wherein the optimum pulse duration is determined for a first phase of a multiphasic pulse cardioversion waveform.

Claim 27

The improved method of claim 16 wherein the optimum pulse duration is a time period that is shorter than a first time constant that is a system time constant, RC, of the implantable cardioverter defibrillator, where R is an inter-electrode resistance of the heart of the human patient and C is an effective capacitance of the capacitor and longer than a second time constant that is an average cardioversion chronaxie value of the heart of the human patient.

Claim 28

The improved method of claim 16 wherein the optimum pulse duration is selected to be between 0.5 ms and 3.0 ms so as to decrease pain induced in the human patient by the cardioversion waveform.

Claim 29

The improved method of claim 26 wherein the optimum pulse duration is between about 0.8 and 1.2 ms.

Claim 30

The improved method of claim 16 wherein the optimum pulse duration is measured by a percentage tilt decay between an initial voltage value and a final voltage value where the percentage tilt is between about 5% and 20%.

Claim 31

The improved method of claim 28 wherein the percentage tilt is between about 12% and 16%.

Claim 32

An improved implantable cardioverter defibrillator apparatus for producing a cardioversion waveform of less than about 5 Joules and a defibrillation waveform of greater than about 5 Joules, both of which are to be delivered to at least two or more implanted electrodes in a human patient the implantable apparatus including capacitor means for storing a preselected amount of electrical energy for the cardioversion waveform, high voltage charging circuit means for charging the capacitor means to the preselected amount of electrical energy, and switch means for selectively controlling a time-truncated discharge of the capacitor means through the plurality of electrodes in response to a means for sensing of the cardiac arrhythmia, the improvement comprising: the switch means including: means for delivering the cardioversion waveform comprising at least one electrical pulse and having a predetermined pulse duration, and means for delivering the defibrillation waveform comprising at least one electrical pulse and having a second predetermined pulse duration, such that the predetermined pulse duration of the cardioversion waveform is less than the second predetermined pulse duration of the defibrillation waveform.

Claim 33

An improved implantable cardioverter defibrillator apparatus for producing a cardioversion waveform of less than about 5 Joules and a defibrillation waveform of greater than about 5 Joules, both of which are to be delivered to at least two or more implanted electrodes in a human patient the implantable apparatus including capacitor means for storing a preselected amount of electrical energy for the cardioversion waveform, high voltage charging circuit means for charging the capacitor means to the preselected amount of electrical energy, and switch means for selectively controlling a time-truncated discharge of the capacitor means through the plurality of electrodes in response to a means for sensing of the cardiac arrhythmia, the improvement comprising: the switch means including: means for delivering the cardioversion waveform comprising at least one electrical pulse and having a predetermined pulse duration, and means for delivering the defibrillation waveform comprising at least one electrical pulse and having a second predetermined pulse duration, such that the predetermined pulse duration of the cardioversion waveform is less than the second predetermined pulse duration of the defibrillation waveform.

Claim 34

An improved method for operating an implantable cardioverter defibrillator for producing a cardioversion waveform of less than about 5 Joules and a defibrillation waveform of greater than about 5 Joules, both of which are to be delivered to a plurality of implanted electrodes in a human patient in response to a sensing of a cardiac arrhythmia in the patient, the implantable cardioverter defibrillator device being a self-contained human implantable device including pulse-generating capacitor system for storing an electrical energy, a battery for internally charging the pulse-generating capacitor system, and a controller for selectively discharging the electrical energy in the pulse-generating capacitor through the plurality of electrodes, the improved method comprising the steps of: (a) in response to a tachycardia arrhythmia, selectively delivering from the electrical energy stored in the capacitor system in the implantable cardioverter defibrillator to the plurality of implanted electrodes a time-truncated cardioversion waveform comprising at least one electrical pulse and having a predetermined pulse duration, and (b) in response to a fibrillation arrhythmia, selectively delivering from the electrical energy stoed in the implantable cardioverter defibrillator to the plurality of implanted electrodes a time-truncated defibrillation waveform comprising at least one electrical pulse and having a second predetermined pulse duration, such that the predetermined pulse duration of the cardioversion waveform is less than the second predetermined pulse duration of the defibrillation waveform.

Claim 35

An improved method for operating an implantable cardioverter defibrillator for producing a cardioversion waveform of less than about 5 Joules and a defibrillation waveform of greater than about 5 Joules, both of which are to be delivered to a plurality of implanted electrodes in a human patient in response to a sensing of a cardiac arrhythmia in the patient, the implantable cardioverter defibrillator device being a self-contained human implantable device including pulse-generating capacitor system for storing an electrical energy, a battery for internally charging the pulse-generating capacitor system, and a controller for selectively discharging the electrical energy in the pulse-generating capacitor through the plurality of electrodes, the improved method comprising the steps of: (a) in response to a tachycardia arrhythmia, selectively delivering from the electrical energy stored in the capacitor system in the implantable cardioverter defibrillator to the plurality of implanted electrodes a time-truncated cardioversion waveform comprising at least one electrical pulse and having a predetermined pulse duration, and (b) in response to a fibrillation arrhythmia, selectively delivering from the electrical energy stoed in the implantable cardioverter defibrillator to the plurality of implanted electrodes a time-truncated defibrillation waveform comprising at least one electrical pulse and having a second predetermined pulse duration, such that the predetermined pulse duration of the cardioversion waveform is less than the second predetermined pulse duration of the defibrillation waveform.